From the magazine LSR 1/2019 | S. 64-69 The following page is 64

Genome Editing – Upcoming Challenges for Life Sciences Law

International Conference of the University of Basel on 10./11. October 2018

I. Introduction

The remarkable development of the CRISPR/Cas-9 genome editing technology represents one of the most significant scientific breakthroughs since years. This method allows in a simple and cheap manner to modify an organism’s genome with unprecedented precision. However, while CRIPSR/Cas-9 offers a great potential for the development of treatments against hitherto uncurable diseases as well as for the development of more robust and higher yielding plants, this technology also imposes significant challenges for life science law. For example, from a legal viewpoint, the question arises whether the legal framework developed for classical genome editing still suffices in view of the new applications and availability of CRISPR/Cas-9. Furthermore, an important issue in patent law is whether plants and animals whose genome has been genetically modified by the CRISPR/Cas-9 technology are actually patentable. From a legal-ethic position, the potentially significant impact of…

Melden sie sich für den LSR Newsletter an und bleiben Sie informiert.